NCT04300790 2025-07-29
METALLICA
MedSIR
Phase 2 Completed
Clinical Trials
28 trialsNCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00984490 2024-02-01
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT01980823 2023-08-30
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Columbia University
Phase EARLY_PHASE1 Completed
NCT04741204 2023-07-06
METBC
Woman's
Phase 4 Withdrawn
NCT05840068 2023-05-03
IGF Level in Breast Cancer Patients Treated With Metformin
Beni-Suef University
Phase 4 Completed
NCT05351021 2023-03-09
Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Mansoura University
Phase 2 Completed
NCT02874430 2022-12-15
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Phase 2 Unknown
NCT00930579 2022-10-20
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
Columbia University
Phase 2 Completed
NCT02278965 2022-08-17
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Columbia University
Phase 1 Completed
NCT04143282 2021-12-07
Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Beni-Suef University
Phase 2 Completed
NCT05053841 2021-09-23
Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women
Tanta University
Phase 2 Completed
NCT04559308 2020-09-22
The Effect of Metformin on Breast Cancer Patients
Beni-Suef University
Phase 2 Unknown
NCT01627067 2020-06-19
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04387630 2020-06-11
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.
Mansoura University
Phase 2/3 Unknown
NCT01302379 2020-06-05
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
University of California, San Diego
Phase NA Completed
NCT04001725 2019-11-13
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT02506777 2019-09-04
MBC1
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Unknown
NCT02506790 2019-09-04
Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Unknown
NCT01793948 2018-03-30
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Indiana University
Phase EARLY_PHASE1 Completed
NCT01650506 2017-08-30
Study of Erlotinib and Metformin in Triple Negative Breast Cancer
Columbia University
Phase 1 Completed
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00933309 2016-02-19
The Impact of Obesity and Obesity Treatments on Breast Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01885013 2016-01-01
MYME
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT00909506 2015-07-29
Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients
Seoul National University Hospital
Phase 2 Completed
NCT01266486 2014-07-02
Effect of Metformin on Breast Cancer Metabolism
Oxford University Hospitals NHS Trust
Phase 2 Completed
NCT01477060 2014-02-20
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
Fondazione Michelangelo
Phase 2 Terminated
NCT00897884 2012-01-19
Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
Mount Sinai Hospital, Canada
Phase NA Completed